FDA reverses course, won't approve leucovorin for autism

Higher autism risk with valproate than topiramate, lamotrigine
Pubblicazione: (2024)

FDA approves first genetic test to help identify risk of developing opioid use disorder
Pubblicazione: (2024)

Memantine improves social impairment in youths with autism spectrum disorder
Pubblicazione: (2025)

FDA facing challenges: GAO
Pubblicazione: (2026)

FDA lifts bans on fruit vapes
Pubblicazione: (2026)

From the FDA: Nicotine pouches can be dangerous to children
Pubblicazione: (2025)

FDA urges higher naloxone doses in fentanyl era
di: Alison Knopf
Pubblicazione: (2024)

Reorganizing the FDA is not a good idea: Former officials
Pubblicazione: (2025)

Ob‐gyns respond to recent FDA discussion on SSRIs in pregnancy
di: Alison Knopf
Pubblicazione: (2025)

FDA warns against accidental overdose on fentanyl patches by children
di: Alison Knopf
Pubblicazione: (2024)

FDA warns against ultra‐processed food risks to children
Pubblicazione: (2025)

Age of autism diagnosis determined by traits as well as genes
di: Alison Knopf
Pubblicazione: (2025)

FDA requests removal of suicide warnings from two GLP‐1 labels
Pubblicazione: (2026)

Prescription stimulant prescribing, nonmedical use, and shortages: US FDA research and response
Pubblicazione: (2025)

Review: Research does not support most promoted medical uses of cannabis
Pubblicazione: (2026)

When both treatments unblinded, psychedelics not more effective than antidepressants
Pubblicazione: (2026)

Approvals
Pubblicazione: (2026)

Clozapine‐induced third‐degree atrioventricular block and respiratory failure
di: Y. W. Francis Lam
Pubblicazione: (2026)

Impact of maternal acetaminophen use on child neurodevelopment
di: Y. W. Francis Lam
Pubblicazione: (2026)

Meta‐analysis finds little benefit from cannabinoids for behavioral disorders
Pubblicazione: (2026)

Ketamine shows long‐term benefit in patients with treatment‐resistant depression
Pubblicazione: (2026)

Network meta‐analysis finds dexmedetomidine broadly effective for postoperative delirium
Pubblicazione: (2026)

Clozapine concentration and adverse reactions: Impact of smoking
di: Y. W. Francis Lam
Pubblicazione: (2026)

Study of young psychiatric patients shows potential preventive benefit of doxycycline
Pubblicazione: (2026)

Alcohol use history predicts antidepressant response to ketamine
Pubblicazione: (2026)

Concurrent metformin improves adherence to SGA treatment
Pubblicazione: (2026)

Your Medication Information
Pubblicazione: (2026)

DBT more efficacious than SSRI in reducing suicidality in borderline personality disorder
Pubblicazione: (2026)

Cohort study: No causal link between psychotropic exposure and obstetric complications
Pubblicazione: (2026)

Benefits of buprenorphine over methadone offset by lower treatment retention
Pubblicazione: (2026)

Antipsychotic dose reduction/discontinuation in first‐episode psychosis carries short‐term risks
Pubblicazione: (2026)

Decision‐support tool shows promise for treatment retention in depression
Pubblicazione: (2026)

Varenicline reduces cannabis use in men in Phase 2 trial
Pubblicazione: (2026)

Ketamine outperforms ECT on cognitive function in patients with treatment‐resistant depression
Pubblicazione: (2026)

Paternal exposure to valproate linked to higher risk of neurodevelopmental disorders in offspring
Pubblicazione: (2026)

Study of children exposed to SSRIs during breastfeeding finds no cognitive risk
Pubblicazione: (2026)